| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3905424 | Urology | 2006 | 5 Pages |
Abstract
PSA-ACT is as useful as total PSA for identifying patients with a low probability of having bone metastasis. PSA-ACT could replace PSA for predicting negative bone scans in a clinical setting in which PSA-ACT is used for monitoring and screening patients for prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Eiji Kikuchi, Jun Nakashima, Midori Ishibashi, Takashi Ohigashi, Mototsugu Oya, Ken Nakagawa, Akira Miyajima, Masaru Murai,